GSK's Flonase zooms to top of allergy category after DTC push

GlaxoSmithKline's ($GSK) big advertising push on over-the-counter Flonase appears to be working. The allergy-fighting nasal spray brought in almost $100 million in sales during its first 16 weeks on the market, making it the biggest seller in the allergy field for the period. Report

Read more on